No current affiliations available for this person. The person is no longer active at the university.

Impaired B Cell Expression of the Inhibitory Fcγ Receptor IIB in Myasthenia Gravis. Keller CW, Chuquisana O, Derdelinckx J, Gross CC, Berger K, Robinson J, Nimmerjahn F, Wiendl H, Willcox N, Lünemann JD (2022) In: Annals of Neurology. Research article (journal)
Complement activation contributes to GAD antibody-associated encephalitis. Chuquisana O, Strippel C, Tröscher AM, Baumgartner T, Rácz A, Keller CW, Elger CE, Melzer N, Kovac S, Wiendl H, Bauer J, Lünemann JD (2022) In: Acta Neuropathologica, 144(2). Research article (journal)
Impaired B Cell Expression of the Inhibitory Fcγ Receptor IIB in Myasthenia Gravis. Keller CW, Chuquisana O, Derdelinckx J, Gross CC, Berger K, Robinson J, Nimmerjahn F, Wiendl H, Willcox N, Lünemann JD (2022) In: Annals of Neurology. Research article (journal)
Reply to "Investigating the Immunopathogenic Mechanisms Underlying MOGAD". Keller CW, Lopez JA, Wendel EM, Ramanathan S, Gross CC, Klotz L, Reindl M, Dale RC, Wiendl H, Rostásy K, Brilot F, Lünemann JD (2022) In: Annals of Neurology, 91(2). Letter to the editor (journal)
Complement Activation Is a Prominent Feature of MOGAD Klotz L., Gross C.C., Dale R.C., Reindl M., Rostásy K., Wiendl H., Lünemann J.D., Brilot F., Keller C.W., Lopez J.A., Wendel E.M., Ramanathan S. (2021) In: Annals of Neurology, 90(6). Research article (journal)